Showing results (2551-2560 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|December 29, 2006
A lifetime modelled economic evaluation comparing pioglitazone and rosiglitazone for the treatment of type 2 diabetes mellitus in the UKDominic P Tilden, Segundo Mariz, Gillies O'Bryan-Tear, et al.Pharmacoeconomics|December 29, 2006
Cost effectiveness of palivizumab for respiratory syncytial virus prophylaxis in high-risk children: a UK analysisMark J C Nuijten, Wolfgang Wittenberg, Maximilian LebmeierPharmacoeconomics|July 21, 2007
Healthcare utilisation and costs associated with adding montelukast to current therapy in patients with mild to moderate asthma and co-morbid allergic rhinitis: PRAACTICAL studyRoberto Dal Negro, Peter Piskorz, Roberto Vives, et al.Pharmacoeconomics|July 21, 2007
Direct costs in patients hospitalised with community-acquired pneumonia after non-response to outpatient treatment with macrolide antibacterials in the USJoseph A Paladino, Martin H Adelman, Jerome J Schentag, et al.Pharmacoeconomics|July 6, 2007
The use of disease-specific outcome measures in cost-utility analysis: the development of Dutch societal preference weights for the FACT-L scaleLeida M Lamers, Carin A Uyl-de Groot, Ivonne BuijtPharmacoeconomics|August 11, 2006
A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trialsDarren J Clayson, Diane J Wild, Paul Quarterman, et al.Pharmacoeconomics|August 11, 2006
A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarctionMark Lamotte, Lieven Annemans, Pawel Kawalec, et al.Pharmacoeconomics|August 11, 2006
Cost effectiveness of adding ezetimibe to atorvastatin therapy in patients not at cholesterol treatment goal in CanadaMichele Kohli, Cheryl Attard, Annette Lam, et al.Pharmacoeconomics|June 29, 2006
Cost of lung cancer: a methodological reviewLaurent Molinier, Christophe Combescure, Cristos Chouaïd, et al.Pharmacoeconomics|September 28, 2006
Single-inhaler combination therapy for asthma: a review of cost effectivenessManabu Akazawa, David A StempelPageof 336